MedPath

Corimmun GmbH

Corimmun GmbH logo
🇩🇪Germany
Ownership
Subsidiary
Established
2006-01-01
Employees
-
Market Cap
-
Website
http://www.corimmun.com

Pilot Study of COR-1 in Heart Failure

Phase 2
Completed
Conditions
Cardiomyopathy, Dilated
Interventions
Drug: 0.9 % sodium chloride
Drug: Standard therapy for heart failure
First Posted Date
2011-07-12
Last Posted Date
2014-10-17
Lead Sponsor
Corimmun GmbH
Target Recruit Count
36
Registration Number
NCT01391507

Safety, Pharmacokinetic and Pharmacodynamic Study of COR-1, an Anti-ß1 Receptor Antibody Cyclopeptide

Phase 1
Completed
Conditions
Heart Failure
Interventions
Drug: placebo
First Posted Date
2010-01-06
Last Posted Date
2013-04-08
Lead Sponsor
Corimmun GmbH
Target Recruit Count
50
Registration Number
NCT01043146
Locations
🇩🇪

ABX-CRO, Goerlitz, Saxonia, Germany

© Copyright 2025. All Rights Reserved by MedPath